Crowdfunding: EyeBrain raises €1.3 million on Anaxago
EyeBrain announced the conclusion of a new round of funding. A total of €1.3 million ($1.47 million) has been raised with the support of EyeBrain’s shareholders, the Fonds Régional de Co-Investissement d’Ile-de-France (FRCI, regional joint investment fund for the Ile-de-France or Greater Paris area) and the Anaxago crowdfunding platform. The FRCI has an exclusive partnership with the crowndfunding platform. This is one of the largest amounts ever raised through crowdfunding by a start-up based in France.
The total raised in this round of funding demonstrates the public interest in health care and the specific neurological and psychiatric disorders that EyeBrain targets. The company develops tools based on the analysis of eye movements, making it possible to test specific regions of the brain. These devices address a gap in the range of diagnostic tools used in neurology and psychiatry. In just 20 minutes and for less than the cost of imaging, EyeBrain’s devices can provide an additional diagnosis with quantifiable, objective results. The device offers a non-invasive alternative to examination techniques such as blood tests or lumbar punctures.
This third round of funding will help EyeBrain to continue the development of its diagnostic products for neurological and psychiatric disorders such as attention deficit hyperactivity disorder (ADHD) and schizophrenia. EyeBrain also intends to boost its sales presence in Europe. Previously, the company raised €1.2 million ($1.36 million) in 2009 from funds managed by CapDecisif Management and from investment fund G1JIDF, then €3.3 million ($3.74 million) in 2012 from its historical investors and Octalfa, Sudinnova and CM-CIC Capital Innovation.
Other news from the department business & finance
